ONCONOVA THERAPEUTICS INC's ticker is ONTX and the CUSIP is 68232V405. A total of 21 filers reported holding ONCONOVA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $205,000 | -70.2% | 241,850 | 0.0% | 0.00% | -75.0% |
| Q2 2019 | $689,000 | -13.7% | 241,850 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $798,000 | +56.5% | 241,850 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $510,000 | -71.3% | 241,850 | 0.0% | 0.00% | -71.4% |
| Q3 2018 | $1,775,000 | – | 241,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYNDALL CAPITAL PARTNERS L P | 816,272 | $2,694,000 | 53.28% |
| 683 Capital Management, LLC | 966,877 | $3,191,000 | 0.29% |
| Kepos Capital LP | 128,229 | $423,000 | 0.03% |
| Point72 Asset Management, L.P. | 241,850 | $798,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,099 | $115,000 | 0.00% |
| CITIGROUP INC | 6 | $0 | 0.00% |
| MORGAN STANLEY | 666 | $2,000 | 0.00% |
| BlackRock Inc. | 43 | $0 | 0.00% |
| Weaver Consulting Group | 284 | $1,000 | 0.00% |